(Q40916988)

24 September 2017

A multinational investigation of the impact of subcutaneous sumatriptan. IV: Patient satisfaction (English)

1 reference

24 September 2017

1 reference

Bouchard J

1

1 reference

24 September 2017

Cortelli P

2

1 reference

24 September 2017

Dahlöf C

3

1 reference

24 September 2017

Heywood J

4

1 reference

24 September 2017

Jansen JP

5

1 reference

24 September 2017

Price KL

6

1 reference

24 September 2017

Pham S

7

1 reference

24 September 2017

Joseph A

8

1 reference

24 September 2017

Babiak L

9

1 reference

24 September 2017

1 January 1997

1 reference

24 September 2017

1 reference

24 September 2017

11 Suppl 1

1 reference

24 September 2017

43-50

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-199700111-00007

24 September 2017

0 references

cites work

A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group

1 reference

12 December 2020

Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group.

1 reference

12 December 2020

A multinational investigation of the impact of subcutaneous sumatriptan. III: Workplace productivity and non-workplace activity

1 reference

12 December 2020

A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life.

1 reference

12 December 2020

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study.

1 reference

12 December 2020

A multinational investigation of the impact of subcutaneous sumatriptan. I: Design, methods and clinical findings

1 reference

12 December 2020

Treatment of Acute Migraine With Subcutaneous Sumatriptan

1 reference

12 December 2020

Oral sumatriptan compared with placebo in the acute treatment of migraine

1 reference

12 December 2020

How does sumatriptan perform in clinical practice?

1 reference

12 December 2020

Patient attitudes about headache

1 reference

12 December 2020

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

12 December 2020

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group

1 reference

12 December 2020

Efficacy of subcutaneous sumatriptan in repeated episodes of migraine

1 reference

12 December 2020

10.2165/00019053-199700111-00007

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference